Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours

Despite the progress in outcomes seen with immunotherapy in various malignancies, including nonsmall cell lung cancer, the benefits are less in small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours. New effective treatment options are needed, guided via more in-depth insights into the pathophysiology of these rare malignancies. This review comprehensively presents an overview of the clinical presentation, diagnostic tools, staging systems, pathophysiology and treatment options for these rare thoracic cancers. In addition, opportunities for further improvement of therapies are discussed.

Source: European Respiratory Review - February 7, 2023 Category: Respiratory Medicine Authors: Dumoulin, D. W., Bironzo, P., Passiglia, F., Scagliotti, G. V., Aerts, J. G. J. V., on behalf of the ERN-LUNG Core Network Mesothelioma Tags: Lung cancer The world of rare lung diseases Source Type: research